Mathes Company’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,191
| Closed | -$499K | – | 127 |
|
|
2024
Q3 | $499K | Sell |
4,191
-154
| -4% | -$18.3K | 0.18% | 89 |
|
|
2024
Q2 | $620K | Sell |
4,345
-265
| -6% | -$37.8K | 0.23% | 80 |
|
|
2024
Q1 | $592K | Sell |
4,610
-100
| -2% | -$12.8K | 0.22% | 84 |
|
|
2023
Q4 | $487K | Sell |
4,710
-255
| -5% | -$26.4K | 0.2% | 90 |
|
|
2023
Q3 | $452K | Buy |
4,965
+1,145
| +30% | +$104K | 0.21% | 89 |
|
|
2023
Q2 | $309K | Buy |
+3,820
| New | +$309K | 0.14% | 105 |
|
|
2022
Q4 | $258K | Buy |
+3,820
| New | +$258K | 0.13% | 112 |
|
|
2022
Q3 | – | Sell |
-3,800
| Closed | -$212K | – | 130 |
|
|
2022
Q2 | $212K | Sell |
3,800
-60
| -2% | -$3.35K | 0.1% | 121 |
|
|
2022
Q1 | $214K | Buy |
3,860
+3,428
| +794% | +$190K | 0.08% | 127 |
|
|
2021
Q4 | $1.93M | Buy |
+432
| New | +$1.93M | 0.66% | 55 |
|